title: Analysis of imatinib and sorafenib binding to p38alpha compared with c-Abl and b-Raf provides structural insights for understanding the selectivity of inhibitors targeting the DFG-out form of protein kinases.
authors.affiliation: Department of Biology, Locus Pharmaceuticals, Inc, Four Valley Square, 512 East Township Line Rd,Blue Bell, Pennsylvania 19422, USA. vnamboodiri@ansarisbio.com
authors.forename: Haridasan V
authors.initials: HV
authors.lastname: Namboodiri
authors.forename: Marina
authors.initials: M
authors.lastname: Bukhtiyarova
authors.forename: Joseph
authors.initials: J
authors.lastname: Ramcharan
authors.forename: Michael
authors.initials: M
authors.lastname: Karpusas
authors.forename: Younghee
authors.initials: Y
authors.lastname: Lee
authors.forename: Eric B
authors.initials: EB
authors.lastname: Springman